A5087635593- HIV Research and Treatment
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Dermatological and COVID-19 studies
- COVID-19 Clinical Research Studies
- HIV-related health complications and treatments
- COVID-19 and healthcare impacts
Universidade Federal do Amazonas
2024-2025
Universidade do Estado do Amazonas
2025
Despite progress in healthcare for people living with HIV/AIDS (PLWHA), many still present advanced HIV, thus increasing their risk of death. Late initiation treatment and poor adherence to antiretroviral therapy (ART) are key contributing factors. This study aimed evaluate cytokines as mortality predictors among hospitalized PLWHA. It assessed the death between ART-naïve ART-non-adherent PLWHA HIV quantified immunological markers post-mortem samples determine influence irregular ART use. A...
Introduction: Despite the efficacy of COVID-19, search for improvements in management severe/critical cases continues to be important. The aim is demonstrate kinetics 4 serological markers patients with COVID-19 who evolved hypoxemia. Methods: From June December 2020, Health Secretariat Rondônia State, Brazil, established a home medical care service team (HMCS) that provided clinical follow-up health professionals and military personnel COVID-19. laboratory monitoring was individualized at...
Virologic failure may occur because of poor treatment adherence and/or viral drug resistance mutations (DRM). In Brazil, the northern region exhibits worst epidemiological scenarios for human immunodeficiency virus (HIV). Thus, this study is aimed at investigating genetic diversity HIV-1 and DRM in Manaus. The cross-sectional included people living with HIV on combined antiretroviral therapy who had experienced virological during 2018-2019. Sequencing protease/reverse transcriptase (PR/RT)...